SEC Form 4 · accession 0001246360-15-002802
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan C Hanson
Officer — EVP & Pres Min Invas Therapies
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 3, 2015 | A | 12,394 | $0.00 | A | 115,090 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $78.00 | Aug 3, 2015 | A | 49,573 | A | Aug 3, 2016 | Aug 3, 2025 | Ordinary Shares | 49,573 | 49,573 | D |
| Employee Stock Option (right to buy)F3 | $78.00 | Aug 3, 2015 | A | 1,283 | A | Aug 3, 2016 | Aug 3, 2025 | Ordinary Shares | 1,283 | 50,856 | D |
Explanation of responses
- F1This balance increased by 257 shares due to exempt transactions such as dividend reinvestment.
- F2The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2018 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee.
- F3These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.